Glioblastoma is a formidable brain tumor known for its fast growth and insensitivity to conventional treatments. Studies are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is